Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Bridget Teevan"'
Autor:
Daniela N. Quilliam, Utpala Bandy, Young June Choe, Bridget Teevan, Michael A. Smit, Leonard A. Mermel
Publikováno v:
Zoonoses and Public Health. 67:331-341
To assess and describe the use of rabies post-exposure prophylaxis (PEP) related to mass bat exposures (MBEs) in the literature and in the state of Rhode Island. Data on MBE events occurring between 2010 and 2016 from the Rhode Island Department of H
Autor:
Eric B. Larson, Martin Darvas, Kimiko Domoto-Reilly, Thomas D. Bird, Jonathan Henriksen, Brian C. Kraemer, Caitlin S. Latimer, Paul K. Crane, C. Dirk Keene, Suman Jayadev, Heather N. Currey, Thomas J. Grabowski, Nicole F. Liachko, Bridget Teevan Burke, Laura E. Gibbons, Mitchell D. Kilgore
Publikováno v:
Acta Neuropathologica Communications, Vol 7, Iss 1, Pp 1-24 (2019)
Acta Neuropathologica Communications
Acta Neuropathologica Communications
Alzheimer’s disease neuropathologic change (ADNC) is defined by progressive accumulation of β-amyloid plaques and hyperphosphorylated tau (pTau) neurofibrillary tangles across diverse regions of brain. Non-demented individuals who reach advanced a
Autor:
Nicole Jepeal, Daren Anderson, Tamim Ahmed, Giuseppe Maci, Victor G. Villagra, Anthony Porto, Bridget Teevan, Emil Coman
Publikováno v:
Health Affairs. 37:2031-2036
Specialty care accounts for a significant and growing portion of year-over-year Medicaid cost increases. Some referrals to specialists may be avoided and managed more efficiently by using electronic consultations (eConsults). In this study a large, m
Autor:
Joshua A. Sonnen, C. Dirk Keene, Susan M. McCurry, Bridget Teevan Burke, Paul K. Crane, Eric B. Larson, James Bowen, Caitlin S. Latimer, Wayne C. McCormick
Publikováno v:
Alzheimers Dement
The AT(N) research framework categorizes eight biomarker profiles using amyloid (A), tauopathy (T), and neurodegeneration (N), regardless of dementia status. We evaluated associations with dementia risk in a community-based cohort by approximating AT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42be68f985843fd0d4c8b70601317320
https://europepmc.org/articles/PMC8875276/
https://europepmc.org/articles/PMC8875276/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thomas J. Montine, Eric B. Larson, James Bowen, Caitlin S. Latimer, C. Dirk Keene, Wayne C. McCormick, Bridget Teevan Burke, Paul K. Crane, Joshua A. Sonnen, Susan M. McCurry
Publikováno v:
SSRN Electronic Journal.
Background: A recent Alzheimer's disease research diagnosis framework groups amyloid (A), tauopathy (T), and neurodegeneration (N) biomarkers into eight AT(N) profiles. We determined prevalence at death of each profile in the Adult Changes in Thought
Autor:
Burke, Bridget Teevan, Latimer, Caitlin S., Keene, Dirk C., Montine, Thomas J., Sonnen, Joshua, McCormick, Wayne, Bowen, James D., McCurry, Susan M., Larson, Eric B., Crane, Paul K.
Publikováno v:
In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2018 14(7) Supplement:P1593-P1595
Autor:
Anna Köttgen, Alan N. Baer, Bridget Teevan Burke, Josef Coresh, Morgan E. Grams, Andrew Law, Mara A. McAdams-DeMarco
Publikováno v:
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 71:536-542
Background It is unclear whether traditional and genetic risk factors in middle age predict the onset of gout in older age. Methods We studied the incidence of gout in older adults using the Atherosclerosis Risk in Communities study, a prospective U.
Autor:
Caitlin S. Latimer, Wayne C. McCormick, Susan M. McCurry, Thomas J. Montine, Eric B. Larson, James Bowen, Paul K. Crane, Bridget Teevan Burke, Dirk C. Keene, Joshua A. Sonnen
Publikováno v:
Alzheimer's & Dementia. 14
Autor:
Alan N. Baer, Andrew Law, Anna Köttgen, Mara A. McAdams-DeMarco, Beverly Gwen Windham, Josef Coresh, Dorry L. Segev, Bridget Teevan Burke
Publikováno v:
Arthritis Care & Research. 67:1730-1738
Objective Gout prevalence is high in older adults and those affected are at risk of physical disability, yet it is unclear whether they have worse physical function. Methods We studied gout, hyperuricemia, and physical function in 5,819 older adults